Literature DB >> 25609580

[Targeted radiological therapy of liver tumors].

F Waneck1.   

Abstract

BACKGROUND: Interventional radiology offers a variety of treatment options for liver tumors. Depending on the tumor entity and the extent of the disease, patients can be treated with a curative or palliative intent. In order to make a decision on the best course of treatment for the individual patient, knowledge about the possible therapies and their limitations is essential.
OBJECTIVES: The aim of this article is a structured listing of targeted radiological therapies for the treatment of liver tumors and an overview of the specific technical aspects and possible limitations.
MATERIALS AND METHODS: This study involved a selective literature search as well as personal experiences in interventional radiological treatment of liver tumors.
CONCLUSION: The wide range of available therapies requires an individual assessment of each patient taking the achievable results into account. The decision for an interventional radiological therapy should be made in an interdisciplinary tumor board.

Entities:  

Mesh:

Year:  2015        PMID: 25609580     DOI: 10.1007/s00117-014-2707-6

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  23 in total

Review 1.  Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: a systematic review.

Authors:  Yun Ku Cho; Hyunchul Rhim; Sangik Noh
Journal:  J Gastroenterol Hepatol       Date:  2011-09       Impact factor: 4.029

2.  [Microwave tumor ablation. New devices, new applications?].

Authors:  R Hoffmann; H Rempp; S Clasen
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

Review 3.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

4.  Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors.

Authors:  T W Leung; W Y Lau; S K Ho; S C Ward; J H Chow; M S Chan; C Metreweli; P J Johnson; A K Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-11-01       Impact factor: 7.038

5.  Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.

Authors:  Katerina Malagari; Mary Pomoni; Alexis Kelekis; Anastasia Pomoni; Spyros Dourakis; Themis Spyridopoulos; Hippokratis Moschouris; Emmanouil Emmanouil; Spyros Rizos; Dimitrios Kelekis
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-24       Impact factor: 2.740

Review 6.  Irreversible electroporation: ready for prime time?

Authors:  David S K Lu; Stephen T Kee; Edward W Lee
Journal:  Tech Vasc Interv Radiol       Date:  2013-12

7.  Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.

Authors:  Laura M Kulik; Brian I Carr; Mary F Mulcahy; Robert J Lewandowski; Bassel Atassi; Robert K Ryu; Kent T Sato; Al Benson; Albert A Nemcek; Vanessa L Gates; Michael Abecassis; Reed A Omary; Riad Salem
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

Review 8.  The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Authors:  Josep M Llovet; Josep Fuster; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

9.  Vessel patency post irreversible electroporation.

Authors:  Govindarajan Narayanan; Shivank Bhatia; Ana Echenique; Rekha Suthar; Katuzka Barbery; Jose Yrizarry
Journal:  Cardiovasc Intervent Radiol       Date:  2014-09-12       Impact factor: 2.740

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.